Cargando…
Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker
Cancer is a systemic disease involving multiple components produced from both tumor cells themselves and surrounding stromal cells. The pro- or anti-tumoral role of the stroma is still under debate. Indeed, it has long been considered the main physical barrier to the diffusion of chemotherapy by its...
Autores principales: | Liot, Sophie, Aubert, Alexandre, Hervieu, Valérie, Kholti, Naïma El, Schalkwijk, Joost, Verrier, Bernard, Valcourt, Ulrich, Lambert, Elise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852205/ https://www.ncbi.nlm.nih.gov/pubmed/33543019 http://dx.doi.org/10.1016/j.mbplus.2020.100021 |
Ejemplares similares
-
Development of thymic tumor in [LSL:Kras(G12D); Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis
por: Liot, Sophie, et al.
Publicado: (2021) -
Latent TGF-β Activation Is a Hallmark of the Tenascin Family
por: Aubert, Alexandre, et al.
Publicado: (2021) -
Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
por: Liot, Sophie, et al.
Publicado: (2021) -
Tenascin-X: beyond the architectural function
por: Valcourt, Ulrich, et al.
Publicado: (2015) -
Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
por: Alcaraz, Lindsay B., et al.
Publicado: (2014)